Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the ...

Multi-epitope immunopurifications of huntingtin (HTT) from vulnerable brain regions of Huntington’s disease (HD) models ...

Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed ...

Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...

Labor Dr. Wisplinghoff will offer GTC's next-generation sequencing-based tests for solid tumor and hematologic neoplasms.

PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for ...

Global Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of USD 60.52 Billion by 2030 at a CAGR of 19.70% during the forecast period, 2022–2028. The ...